Dr Graham is a Consultant Clinical Oncologist with special interest in non surgical cancer treatment of the breast.
Dr Graham is the Chief investigator on 3 ongoing prostate cancer trials including the first ever Phase lll trial approved by the Gene Therapy Advisory Committee (CellGenesys G-0029). He set up the conformal radiotherapy service for prostate cancer in Bristol, and is a member of the steering committee for the MRC RT01 study of dose escalation in prostate cancer. IMRT set up in Glasgow and trialled the first patient in Scotland with IMRT in November 2005, recruited to the CHHIP trail of IMRT in prostate cancer. He is a member of the Trial Management Group for this trial and plans to set up IMRT for prostate cancer in Taunton.
- Royal College of Radiologist
- European Organisation for Research and Treatment of Cancer
- Academic Clinical Oncology Radiation Research UK
Other post held
- Nuffield Health Taunton Hospital
- Musgrove Park Hospital, Taunton &
- Somerset NHS Foundation Trust
Insurers Dr John Graham works with
Dr John Graham works with the following private medical insurance providers:
- Aviva Health
- AXA PPP Healthcare
- Exeter Family Friendly
Dr John Graham does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr John Graham does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr John Graham does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.